Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
NVNeovasc Inc. logo

Neovasc Inc. (NVCN)

NASDAQ Capital Market · Currency in USD
$30.03 ▲ +0.00 (+0.00%)
At close: Apr 10, 4:00 PM ET. Market closed.

Summary

Previous Close
$30.03
Open
$29.59
Day's Range
$29.43 – $30.07
52 Week Range
$4.59 – $30.07
Volume
1
Avg. Volume
25,784
Market Cap
$82.86M
Beta (5Y Monthly)
2.01
PE Ratio (TTM)
--
EPS (TTM)
-$15.07
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Neovasc Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
49
CEO
Fredericus A. Colen

Neovasc Inc. is a specialized medical technology enterprise focused on the development, production, and worldwide distribution of products for the cardiac health sector, with a significant presence across Europe and other international markets. The company's key innovations feature the Tiara system, an advanced transcatheter technology for managing mitral valve disease, and the Neovasc Reducer, which offers a therapeutic option for patients suffering from refractory angina. Founded in 2000, the organization initially operated as Medical Ventures Corp. before adopting the name Neovasc Inc. in July 2008.

Earnings

DateEst.Actual
Mar 31, 2023-$2.71-$5.03Miss
Dec 31, 2022–-$5.06
Nov 10, 2022-$2.82-$3.00Miss
Aug 11, 2022-$1.80-$3.29Miss
May 12, 2022-$1.25-$3.75Miss
Mar 10, 2022-$2.50-$2.27Beat

Analyst view

Rating: Buy
Buy 86% · Hold 14% · Sell 0%

Get free alerts on NVCN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.